In this edition of AI Prognosis, Brittany Trang raises the question: What kind of health data would we need to train AI ...

Faced with stiff local opposition and a possible loss in court, PeaceHealth drops plan to replace Eugene Emergency Physicians ...

Sanofi has asked the FDA to pull its type 1 diabetes drug out of Commissioner Marty Makary’s new speedy drug review program.

The analysis estimated the drug companies’ pledge to offer all new drugs at most-favored nation pricing would save the U.S.

Marty Makary says he was "skeptical initially" about flavored vapes but that age-gating technology could limit their use.

I have spent the last 10 years of my life investigating psychedelics as novel treatments for mental health conditions. When ...

Cell and gene therapy makers met in Rome to discuss the field's outlook in Europe. One main topic of conversation: the FDA.

According to CDC data, just over 13% of adults have reported using an anti-depressant. Last year, HHS released a report ...

Policy recommendations in OpenAI's blueprint for unlocking AI’s potential to change health care are reasonable, but also self ...

A Cytokinetics heart disease drug — already approved in one indication — succeeded in another Phase 3 trial, a potential boost for sales.

His real name is Will Flanary, but you probably know him as Dr. Glaucomflecken — the internet’s go-to doctor/comedian. On ...

Karlawish is a professor of medicine, medical ethics, health policy, and neurology at the University of Pennsylvania’s ...